| Identification of ROS1 rearrangement in gastric adenocarcinoma J Lee, SE Lee, SY Kang, IG Do, S Lee, SY Ha, J Cho, WK Kang, J Jang, ... Cancer 119 (9), 1627-1635, 2013 | 157 | 2013 |
| Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma J Kim, C Fox, S Peng, M Pusung, E Pectasides, E Matthee, YS Hong, ... The Journal of clinical investigation 124 (12), 5145-5158, 2014 | 124 | 2014 |
| Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations J Lee, I Lee, B Han, JO Park, J Jang, C Park, WK Kang JNCI: Journal of the National Cancer Institute 103 (8), 674-688, 2011 | 117 | 2011 |
| High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma J Lee, P Van Hummelen, C Go, E Palescandolo, J Jang, HY Park, ... PloS one 7 (6), e38892, 2012 | 105 | 2012 |
| MicroRNA expression profiles in gastric carcinogenesis J Hwang, BH Min, J Jang, SY Kang, H Bae, SS Jang, JI Kim, KM Kim Scientific reports 8 (1), 14393, 2018 | 82 | 2018 |
| The effect of acupuncture on anxiety and neuropeptide Y expression in the basolateral amygdala of maternally separated rats HJ Park, Y Chae, J Jang, I Shim, H Lee, S Lim Neuroscience Letters 377 (3), 179-184, 2005 | 82 | 2005 |
| KIT amplification and gene mutations in acral/mucosal melanoma in Korea J Yun, J Lee, J Jang, EJ Lee, KT Jang, JH Kim, KMEE KIM Apmis 119 (6), 330-335, 2011 | 80 | 2011 |
| Exome sequencing identifies early gastric carcinoma as an early stage of advanced gastric cancer G Kang, WC Hwang, IG Do, K Wang, SY Kang, J Lee, SH Park, JO Park, ... PloS one 8 (12), e82770, 2013 | 70 | 2013 |
| P21-activated kinase 4 overexpression in metastatic gastric cancer patients HK Ahn, J Jang, J Lee, HP Se, JO Park, YS Park, HY Lim, KM Kim, ... Translational oncology 4 (6), 345-349, 2011 | 67 | 2011 |
| NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line SJ Lee, GG Li, ST Kim, ME Hong, J Jang, N Yoon, SM Ahn, D Murphy, ... Oncotarget 6 (36), 39028, 2015 | 66 | 2015 |
| Gastrointestinal malignancies harbor actionable MET exon 14 deletions J Lee, SHI Ou, JM Lee, HC Kim, M Hong, SY Kim, J Jang, S Ahn, SY Kang, ... Oncotarget 6 (29), 28211, 2015 | 66 | 2015 |
| Patient-derived cell models as preclinical tools for genome-directed targeted therapy JY Lee, SY Kim, C Park, NKD Kim, J Jang, K Park, JH Yi, M Hong, T Ahn, ... Oncotarget 6 (28), 25619, 2015 | 56 | 2015 |
| Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion SY Kim, T Ahn, H Bang, JS Ham, J Kim, ST Kim, J Jang, M Shim, SY Kang, ... Oncotarget 8 (9), 15014, 2017 | 52 | 2017 |
| Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer ST Kim, I Sohn, IG Do, J Jang, SH Kim, SINHO JUNG, JO Park, YS Park, ... Cancer genomics & proteomics 11 (5), 259-266, 2014 | 51 | 2014 |
| High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations CH Maeng, J Lee, P van Hummelen, SH Park, E Palescandolo, J Jang, ... Public Library of Science 7 (8), e41655, 2012 | 50 | 2012 |
| HER2‐positive gastric cancer with concomitant MET and/or EGFR overexpression: A distinct subset of patients for dual inhibition therapy SY Ha, J Lee, J Jang, JY Hong, IG Do, SH Park, JO Park, MG Choi, ... International journal of cancer 136 (7), 1629-1635, 2015 | 45 | 2015 |
| Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening J Lee, HC Kim, JY Hong, K Wang, SY Kim, J Jang, ST Kim, JO Park, ... Oncotarget 6 (27), 24320, 2015 | 43 | 2015 |
| A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers J Lee, S Kim, P Kim, X Liu, T Lee, KM Kim, IG Do, JO Park, SH Park, ... PLoS One 8 (1), e54644, 2013 | 42 | 2013 |
| Aberrant CDK4 amplification in refractory rhabdomyosarcoma as identified by genomic profiling S Park, J Lee, IG Do, J Jang, K Rho, S Ahn, L Maruja, SJ Kim, KM Kim, ... Scientific reports 4 (1), 3623, 2014 | 40 | 2014 |
| Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors SJ Lee, IG Do, J Lee, KM Kim, J Jang, I Sohn, WK Kang Targeted oncology 8, 271-280, 2013 | 38 | 2013 |
